Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

pegzerepoetin alfa

A pegylated form of recombinant human erythropoietin, a glycosylated protein naturally produced in the kidney that stimulates erythrocyte production in the bone marrow. Pegzerepoetin alfa may reverse anemias induced by cancer therapy.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	continuous erythropoietin receptor activator methoxy polyethylene glycol-epoetin beta
US brand name:	Mircera
Code name:	R744 Ro 50-3821

pegzerepoetin alfa

Search NCI's Drug Dictionary